Endoscopic and clinicopathological characteristics of gastrointestinal adult T-cell leukemia/lymphoma.

Adult T-cell leukemia/lymphoma (ATLL) endoscopy gastroenteropathy gastrointestinal tract

Journal

Journal of gastrointestinal oncology
ISSN: 2078-6891
Titre abrégé: J Gastrointest Oncol
Pays: China
ID NLM: 101557751

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 9 8 2019
pubmed: 9 8 2019
medline: 9 8 2019
Statut: ppublish

Résumé

Adult T-cell leukemia/lymphoma (ATLL) frequently involves the gastrointestinal (GI) tract, and patients mainly show an aggressive clinical course despite of intensive cytotoxic treatments. We investigated the characteristic clinicopathological and endoscopic features of GI ATLL. This was a retrospective analysis of 61 GI tract lesions in 54 ATLL patients. Thirty-six (67%) patients were classified as having lymphoma-type ATLL and 18 (33%) patients were classified as having acute-type with leukemic changes. Examined ATLL lesions in the stomach and intestine (small intestine and colorectum) were 40 (66%) and 21 (34%), respectively. Gastric ATLL lesions were frequently found in the lymphoma-type (29/38; 76%) compared with the acute-type lesions (11/23; 48%; P=0.023). Intestinal ATLL lesions were frequent in the acute-type (12/23; 52%) compared with the lymphoma-type lesions (9/38; 24%; P=0.023). Endoscopically, tumor-forming type lesions were significantly more frequent in lymphoma-type ATLL lesions (29/38 lesions; 76%) compared with acute-type lesions (10/23; 44%; P=0.0096). The superficial spreading-type was significantly more frequent in acute-type lesions (12/23 lesions; 52%) compared with lymphoma-type lesions (3/38; 8%; P=0.0003). Additionally, gastropathy-, enteropathy-, or proctocolitis-like lesions were distinct features, mainly in the acute type (9/23 lesions; 39%). Twenty three of 39 tumor-forming-type lesions (59%) were significantly composed of pleomorphic or anaplastic large cell lymphoma, and 13 of 15 superficial spreading-type lesions (87%) were significantly composed of pleomorphic medium-sized cells (P=0.007, in each). Six patients (11%) who were estimated as having primary GI ATLL based on restricted clinical stages, showed a significantly better overall survival (OS) compared with the 48 advanced-stage patients (P=0.017). Twenty patients with solitary tumor-forming-type lesions showed a significantly better OS than 17 patients with the multiple tumor-forming-type (P=0.015) and five with the mucosal-thickening-type lesions (P=0.04). Twenty-six patients with pleomorphic or anaplastic large cell ATLL showed a significantly better prognosis compared with 28 patients with pleomorphic medium-sized ATLL (P=0.034). ATLL predominantly involves the stomach. Leukemic behavior of ATLL had a large influence on the tumor location and endoscopic features of GI tract lesions. Gastropathy-, enteropathy-, and proctocolitis-like lesions showed additional distinct characteristics. Primary GI ATLL in the early clinical stages, solitary tumor-forming-type lesions and large tumor cells showed better prognostic factors than other factors, respectively.

Sections du résumé

BACKGROUND BACKGROUND
Adult T-cell leukemia/lymphoma (ATLL) frequently involves the gastrointestinal (GI) tract, and patients mainly show an aggressive clinical course despite of intensive cytotoxic treatments. We investigated the characteristic clinicopathological and endoscopic features of GI ATLL.
METHODS METHODS
This was a retrospective analysis of 61 GI tract lesions in 54 ATLL patients.
RESULTS RESULTS
Thirty-six (67%) patients were classified as having lymphoma-type ATLL and 18 (33%) patients were classified as having acute-type with leukemic changes. Examined ATLL lesions in the stomach and intestine (small intestine and colorectum) were 40 (66%) and 21 (34%), respectively. Gastric ATLL lesions were frequently found in the lymphoma-type (29/38; 76%) compared with the acute-type lesions (11/23; 48%; P=0.023). Intestinal ATLL lesions were frequent in the acute-type (12/23; 52%) compared with the lymphoma-type lesions (9/38; 24%; P=0.023). Endoscopically, tumor-forming type lesions were significantly more frequent in lymphoma-type ATLL lesions (29/38 lesions; 76%) compared with acute-type lesions (10/23; 44%; P=0.0096). The superficial spreading-type was significantly more frequent in acute-type lesions (12/23 lesions; 52%) compared with lymphoma-type lesions (3/38; 8%; P=0.0003). Additionally, gastropathy-, enteropathy-, or proctocolitis-like lesions were distinct features, mainly in the acute type (9/23 lesions; 39%). Twenty three of 39 tumor-forming-type lesions (59%) were significantly composed of pleomorphic or anaplastic large cell lymphoma, and 13 of 15 superficial spreading-type lesions (87%) were significantly composed of pleomorphic medium-sized cells (P=0.007, in each). Six patients (11%) who were estimated as having primary GI ATLL based on restricted clinical stages, showed a significantly better overall survival (OS) compared with the 48 advanced-stage patients (P=0.017). Twenty patients with solitary tumor-forming-type lesions showed a significantly better OS than 17 patients with the multiple tumor-forming-type (P=0.015) and five with the mucosal-thickening-type lesions (P=0.04). Twenty-six patients with pleomorphic or anaplastic large cell ATLL showed a significantly better prognosis compared with 28 patients with pleomorphic medium-sized ATLL (P=0.034).
CONCLUSIONS CONCLUSIONS
ATLL predominantly involves the stomach. Leukemic behavior of ATLL had a large influence on the tumor location and endoscopic features of GI tract lesions. Gastropathy-, enteropathy-, and proctocolitis-like lesions showed additional distinct characteristics. Primary GI ATLL in the early clinical stages, solitary tumor-forming-type lesions and large tumor cells showed better prognostic factors than other factors, respectively.

Identifiants

pubmed: 31392053
doi: 10.21037/jgo.2019.03.03
pii: jgo-10-04-723
pmc: PMC6657316
doi:

Types de publication

Journal Article

Langues

eng

Pagination

723-733

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors have no conflicts of interest to declare.

Références

J Natl Cancer Inst. 2000 Aug 2;92(15):1240-51
pubmed: 10922409
Gastrointest Endosc. 2003 Nov;58(5):805-8
pubmed: 14997894
Gastroenterology. 2007 May;132(5):1902-11
pubmed: 17484883
Br J Haematol. 1991 Nov;79(3):428-37
pubmed: 1751370
Intern Med. 2007;46(21):1783-7
pubmed: 17978535
Histopathology. 2009 Dec;55(6):641-53
pubmed: 20002766
Best Pract Res Clin Gastroenterol. 2010 Feb;24(1):43-56
pubmed: 20206108
Histopathology. 2011 Feb;58(3):395-407
pubmed: 21323966
Am J Hematol. 2012 Jul;87(7):663-8
pubmed: 22641357
Scand J Immunol. 2013 Feb;77(2):125-34
pubmed: 23126599
J Clin Gastroenterol. 2013 Sep;47(8):e74-9
pubmed: 23948755
J Gastroenterol Hepatol. 2014 May;29(5):934-43
pubmed: 24325295
Gut Liver. 2016 Jan;10(1):147-51
pubmed: 26260757
Am J Surg Pathol. 2016 Apr;40(4):462-70
pubmed: 26813744
Hematol Oncol. 2017 Mar;35(1):3-16
pubmed: 27353398
Diagn Pathol. 2016 Jul 25;11(1):66
pubmed: 27457239
Lancet. 1987 Jul 18;2(8551):158-9
pubmed: 2885619
Medicine (Baltimore). 2018 Jan;97(1):e9583
pubmed: 29505542
Leuk Lymphoma. 2019 Apr;60(4):934-939
pubmed: 30277105
Cancer. 1988 Feb 15;61(4):824-8
pubmed: 3257406
Leuk Lymphoma. 1995 Feb;16(5-6):407-12
pubmed: 7787750
Ann Oncol. 1994 May;5(5):397-400
pubmed: 8075046
Cancer. 1996 Aug 1;78(3):396-402
pubmed: 8697382

Auteurs

Hideki Ishibashi (H)

Department of Gastroenterology and Medicine, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Satoshi Nimura (S)

Department of Pathology, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Yoshiyuki Kayashima (Y)

Department of Gastroenterology and Medicine, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Yasushi Takamatsu (Y)

Division of Medical Oncology, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Hiroki Iwasaki (H)

Department of Hematology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.

Naohiko Harada (N)

Department of Gastroenterology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.

Seiya Momosaki (S)

Department of Pathology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.

Hidenori Takedatsu (H)

Department of Gastroenterology and Medicine, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Shotaro Sakisaka (S)

Department of Gastroenterology and Medicine, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Morishige Takeshita (M)

Department of Pathology, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Classifications MeSH